1 - Anemia process measureOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) hemodialysis and peritoneal dialysis patients prescribed an ESA at any time during the study period or who have a Hb<11.0 g/dL in at least one month of the study period for whom serum ferritin concentration and percent transferrin saturation (TSAT) are measured at least once in a three-month period
Type: Process
2 - Iron therapyOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) hemodialysis and peritoneal dialysis patients with hemoglobin<11.0 g/dL and in whom simultaneous values of serum ferritin concentration was <100 ng/ml and TSAT<20% who received IV iron or were prescribed oral iron within the following three months
Type: Process
3 - Clinically Confirmed Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of clinically confirmed infection among HD patients prescribed IV antibiotics
Type: Process
4 - Clinically Confirmed Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of clinically confirmed infection with IV antibiotic therapy among adult chronic HD patients
Type: Process
5 - Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of bacteremia with IV antibiotic therapy, among adult chronic HD patients
Type: Process
6 - Bacteremia (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of bacteremia among adult chronic HD patients prescribed IV antibiotics
Type: Process
7 - VA-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of hemodialysis vascular access-related infection with IV antibiotic therapy among adult chronic HD patients
Type: Process
8 - VA-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis access-related infection among adult chronic HD patients with a clinically confirmed infection and prescribed IV antibiotics
Type: Process
9 - VA-Related Bacteremia (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of bacteremia among adult chronic HD patients with a hemodialysis access-related infection and prescribed IV antibiotics
Type: Process
10 - Catheter-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis catheter-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
11 - Graft-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis arteriovenous graft-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
12 - Fistula-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis arteriovenous fistula-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
13 - Catheter-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using a catheter for hemodialysis access
Type: Process
14 - Graft-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous graft for hemodialysis access
Type: Process
15 - Fistula-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous fistula for hemodialysis access
Type: Process
16 - Catheter-Related Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related bacteremia with IV antibiotic therapy, among adult chronic HD patients using a catheter for hemodialysis access
Type: Process
17 - Graft-Related Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related bacteremia with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous graft for hemodialysis access
Type: Process
18 - Fistula-Related Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related bacteremia with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous fistula for hemodialysis access
Type: Process
19 - Unavailable Clinical Confirmation (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of “unavailable” information regarding clinical confirmation of infection among adult chronic HD patients with new IV antibiotic prescription
Type: Process
20 - Unavailable Blood Culture Results (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of “unavailable” blood culture results for adult chronic HD patients with new IV antibiotic prescription
Type: Process
